Law firm probes Select Medical $16.50/share buyout for fairness to investors.

Kaskela Law is investigating the proposed $16.50 per share buyout of Select Medical Holdings Corp. to assess if the offer fairly compensates shareholders. The buyout would end public trading of Select Medical shares. The investigation questions whether company leaders fulfilled their duties and if the price undervalues the stock, as some analysts had a $19 target. Shareholders are encouraged to contact Kaskela Law to explore legal options for additional compensation.